ACLX-9.28%8.3%
AVBP+60.35%8.3%
CGEM+123.48%8.3%
CRSP-6.90%8.3%
JANX-33.83%8.3%
NRIX+140.15%8.3%
NUVB+171.06%8.3%
NUVL+60.51%8.3%
PTGX+154.93%8.3%
RIGL+35.79%8.3%
RVMD+438.04%8.3%
ZYME+89.36%8.3%
As of Aug 6, 2026, 4:25 AM ET
Biotech '25: Oncology & Immunotherapy Constituents
Arcellx, Inc.ACLX | 8.3% | 0.00% | 0.00% | 0.00% | 0.00% | -1.67% | 0.00% | -4.64% | -9.28% | $3.75B |
ArriVent BioPharma, Inc.AVBP | 8.3% | -2.79% | -3.53% | -11.25% | 2.65% | 52.14% | 33.26% | 70.06% | 60.35% | $1.43B |
CRISPR Therapeutics AGCRSP | 8.3% | -1.17% | 12.70% | -15.25% | 9.29% | 0.02% | -12.79% | 53.41% | -6.90% | $5.06B |
Cullinan Therapeutics, Inc.CGEM | 8.3% | 0.34% | 2.98% | -1.12% | 6.73% | 70.14% | 13.61% | 125.19% | 123.48% | $1.08B |
Janux Therapeutics, Inc.JANX | 8.3% | 0.25% | 4.37% | 3.83% | 5.47% | 15.94% | 17.56% | -43.36% | -33.83% | $975.7M |
Nurix Therapeutics, Inc.NRIX | 8.3% | 1.74% | 7.44% | 4.49% | 8.23% | 32.42% | 57.29% | 120.74% | 140.15% | $2.61B |
Nuvalent, Inc.NUVL | 8.3% | 0.00% | 0.00% | 0.19% | 0.00% | 23.23% | 21.59% | 75.93% | 60.51% | $9.13B |
Nuvation Bio Inc.NUVB | 8.3% | -1.09% | -0.78% | 13.75% | 0.63% | -28.91% | 7.78% | 255.87% | 171.06% | $2.21B |
Protagonist Therapeutics, Inc.PTGX | 8.3% | 1.11% | 0.89% | 4.43% | 0.50% | 57.22% | 49.13% | 184.90% | 154.93% | $8.83B |
Revolution Medicines, Inc.RVMD | 8.3% | 1.98% | 4.26% | 3.85% | 5.21% | 147.71% | 93.39% | 470.23% | 438.04% | $41.95B |
Rigel Pharmaceuticals, Inc.RIGL | 8.3% | 4.60% | 10.18% | 0.56% | 9.97% | -5.49% | 16.52% | 122.30% | 35.79% | $749.0M |
Zymeworks Inc.ZYME | 8.3% | 3.12% | 2.80% | -7.22% | 7.11% | -10.75% | 0.90% | 97.15% | 89.36% | $1.73B |
| Theme return | — | 0.67% | 3.44% | -0.18% | 4.35% | 29.80% | 27.31% | 132.37% | 99.34% | — |
| Average | 8.3% | 0.67% | 3.44% | -0.31% | 4.65% | 29.33% | 24.85% | 127.32% | 101.97% | $6.63B |
| Median | 8.3% | 0.30% | 2.89% | 0.38% | 5.34% | 19.59% | 17.04% | 108.95% | 74.94% | $2.41B |
| Std Dev | 0.0% | 1.92% | 4.53% | 7.47% | 3.59% | 45.86% | 28.24% | 127.91% | 120.10% | $11.00B |
| Min | 8.3% | -2.79% | -3.53% | -15.25% | 0.00% | -28.91% | -12.79% | -43.36% | -33.83% | $749.0M |
| Max | 8.3% | 4.60% | 12.70% | 13.75% | 9.97% | 147.71% | 93.39% | 470.23% | 438.04% | $41.95B |
| % Positive Tickers | 58.33% | 66.67% | 58.33% | 83.33% | 66.67% | 83.33% | 83.33% | 75.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Biotech '25: Oncology & Immunotherapy tracks 12 publicly listed stocks in this theme: ACLX, AVBP, CGEM, CRSP, JANX, NRIX, NUVB, NUVL, PTGX, RIGL, RVMD, ZYME. See the constituent table for details.